|
1
|
Boedefeld WM, Bland KI and Heslin MJ:
Recent insights into angiogenesis, apoptosis, invasion, and
metastasis in colorectal carcinoma. Ann Surg Oncol. 10:839–851.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tutton MG, George ML, Eccles SA, Burton S,
Swift RI and Abulafi AM: Use of plasma MMP-2 and MMP-9 levels as a
surrogate for tumour expression in colorectal cancer patients. Int
J Cancer. 107:541–550. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bensky D, Gamble A and Kaptchuk TK:
Chinese Herbal Medicine Materia Medica. Eastland Press; Seattle:
pp. 358–359. 1993
|
|
5
|
Zee-Cheng RK: Shi-quan-da-bu-tang (ten
significant tonic decoction), SQT. A potent Chinese biological
response modifier in cancer immunotherapy, potentiation and
detoxification of anticancer drugs. Methods Find Exp Clin
Pharmacol. 14:725–736. 1992.
|
|
6
|
Shao BM, Xu W, Dai H, Tu P, Li Z and Gao
XM: A study on the immune receptors for polysaccharides from the
roots of Astragalus membranaceus, a Chinese medicinal herb.
Biochem Biochem Biophys Res Commun. 320:1103–1111. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Duan P and Wang ZM: Clinical study on
effect of Astragalus in efficacy enhancing and toxicity
reducing of chemotherapy in patients of malignant tumor. Zhongguo
Zhong Xi Yi Jie He Za Zhi. 22:515–517. 2002.(In Chinese).
|
|
8
|
Tin MM, Cho CH, Chan K, James AE and Ko
JK: Astragalus saponins induce growth inhibition and
apoptosis in human colon cancer cells and tumor xenograft.
Carcinogenesis. 28:1347–1355. 2007. View Article : Google Scholar
|
|
9
|
Auyeung KK, Cho CH and Ko JK: A novel
anticancer effect of Astragalus saponins: transcriptional
activation of NSAID-activated gene. Int J Cancer. 125:1082–1091.
2009.PubMed/NCBI
|
|
10
|
Shen P, Liu MH, Ng TY, Chan YH and Yong
EL: Differential effects of isoflavones, from Astragalus
membranaceus and Pueraria thomsonii, on the activation
of PPARalpha, PPARgamma, and adipocyte differentiation in vitro. J
Nutr. 136:899–905. 2006.PubMed/NCBI
|
|
11
|
Vaya J, Belinky PA and Aviram M:
Antioxidant constituents from licorice roots: isolation, structure
elucidation and antioxidant capacity toward LDL oxidation. Free Rad
Biol Med. 23:302–312. 1997. View Article : Google Scholar
|
|
12
|
Park J, Kim SH, Cho D and Kim TS:
Formononetin, a phyto-oestrogen, and its metabolites up-regulate
interleukin-4 production in activated T cells via increased AP-1
DNA binding activity. Immunology. 116:71–81. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jun M, Hong J, Jeong WS and Ho CT:
Suppression of arachidonic acid metabolism and nitric oxide
formation by kudzu isoflavones in murine macrophages. Mol Nutr Food
Res. 49:1154–1159. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nestel P, Fujii A and Zhang L: An
isoflavone metabolite reduces arterial stiffness and blood pressure
in overweight men and postmenopausal women. Atherosclerosis.
192:184–189. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huo Y, Guo C, Zhang QY, Chen WS, Zheng HC,
Rahman K and Qin LP: Antinociceptive activity and chemical
composition of constituents from Caragana microphylla seeds.
Phytomedicine. 14:143–146. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dong TTX, Zhao KJ, Gao QT, et al: Chemical
and biological assessment of a chinese herbal decoction containing
Radix Astragali and Radix Angelicae Sinensis:
determination of drug ratio in having optimized properties. J Agric
Food Chem. 54:2767–2774. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Auyeung KK and Ko JK: Novel herbal
flavonoids promote apoptosis but differentially induce cell cycle
arrest in human colon cancer cell. Invest New Drugs. 28:1–13. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Albini A, Iwamoto Y, Kleinman HK, Martin
GR, Aaronson SA, Kozlowski JM and McEwan RN: A rapid in vitro assay
for quantitating the invasive potential of tumor cells. Cancer Res.
47:3239–3245. 1987.PubMed/NCBI
|
|
19
|
Auyeung KK, Law PC and Ko JK:
Astragalus saponins induce apoptosis via an ERK-independent
NF-κB signaling pathway in the human hepatocellular HepG2 cell
line. Int J Mol Med. 23:189–196. 2009.
|
|
20
|
Ko JKS, Lam FYL and Cheung APL:
Amelioration of experimental colitis by Astragalus
membranaceus through anti-oxidation and inhibition of adhesion
molecule synthesis. World J Gastroenterol. 11:5787–5794. 2005.
|
|
21
|
Kondo Y, Arii S, Mori A, Furutani M, Chiba
T and Imamura M: Enhancement of angiogenesis, tumor growth, and
metastasis by transfection of vascular endothelial growth factor
into LoVo human colon cancer cell line. Clin Cancer Res. 6:622–630.
2000.PubMed/NCBI
|
|
22
|
Sukhthankar M, Yamaguchi K, Lee SH,
McEntee MF, Eling TE, Hara Y and Baek SJ: A green tea component
suppresses posttranslational expression of basic fibroblast growth
factor in colorectal cancer. Gastroenterology. 134:1972–1980. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Carusi D: Phytoestrogens as hormone
replacement therapy: an evidence-based approach. Prim Care Update
Ob Gyns. 7:253–259. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liang WC, Wu X, Peale FV, Lee CV, et al:
Cross-species vascular endothelial growth factor (VEGF)-blocking
antibodies completely inhibit the growth of human tumor xenografts
and measure the contribution of stromal VEGF. J Biol Chem.
28:951–961. 2006. View Article : Google Scholar
|
|
25
|
Arjmandi BH: The role of phytoestrogens in
the prevention and treatment of osteoporosis in ovarian hormone
deficiency. J Am Coll Nutr. 20:S398–S402. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fotsis T, Pepper M, Adlercreutz H,
Fleischmann G, Hase T, Montesano R and Schweigerer L: Genistein, a
dietary-derived inhibitor of in vitro angiogenesis. Proc Nat Acad
Sci USA. 90:2690–2694. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yanagihara K, Ito A, Toge T and Numoto M:
Antiproliferative effects of isoflavones on human cancer cell lines
established from the gastrointestinal tract. Cancer Res.
3:5815–5821. 1993.PubMed/NCBI
|
|
28
|
Beck V, Rohr U and Jungbauer A:
Phytoestrogens derived from red clover: an alternative to estrogen
replacement therapy? J Steroid Biochem Mol Biol. 94:499–518. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Harris AL: Angiogenesis as a new target
for cancer control. Eur J Cancer Suppl. 1:1–12. 2003. View Article : Google Scholar
|
|
30
|
Fukumura D, Xavier R and Sugiura T: Tumor
induction of VEGF promoter activity in stromal cells. Cell.
94:715–725. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hanahan D, Christofori G, Naik P and
Arbeit J: Transgenic mouse models of tumour angiogenesis: the
angiogenic switch, its molecular controls, and prospects for
preclinical therapeutic models. Eur J Cancer. 32A:2386–2393. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hanahan D and Folkman J: Patterns and
emerging mechanisms of the angiogenic switch during tumorigenesis.
Cell. 86:353–364. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Takebayashi Y, Aklyama S, Yamada K, Akiba
S and Aikou T: Angiogenesis as an unfavorable prognostic factor in
human colorectal carcinoma. Cancer. 78:226–231. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Vermeulen PB, Van den Eynden GG and Huget
P: Prospective study of intratumoral microvessel density, p53
expression and survival in colorectal cancer. Br J Cancer.
79:316–322. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Portera CA Jr, Berman RS and Ellis LM:
Molecular determinants of colon cancer metastasis. Surg Oncol.
7:183–195. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gutman M and Fidler IJ: Biology of human
colon cancer metastasis. World J Surg. 19:226–234. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Radinsky R and Ellis LM: Molecular
determinants of colon cancer metastasis. Surg Oncol Clin N Am.
5:215–229. 1996.
|
|
38
|
Gabbert H: Mechanisms of tumor invasion:
evidence from in vivo observations. Cancer Metastasis Rev.
4:293–309. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
London CA, Sekhon HS, Arora V, Stein DA,
Iversen PL and Devi GR: A novel antisense inhibitor of MMP-9
attenuates angiogenesis, human prostate cancer cell invasion and
tumorigenicity. Cancer Gene Ther. 10:823–832. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nakahara H: Transmembrane/cytoplasmic
domain-mediated membrane type 1-matrix metalloprotease docking to
invadopodia is required for cell invasion. Proc Natl Acad Sci USA.
94:7959–7964. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Coussens LM, Fingleton B and Matrisian LM:
Matrix metalloproteinase inhibitors and cancer: trials and
tribulations. Science. 295:2387–2392. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fridman R, Toth M, Chvyrkova I, Meroueh SO
and Mobashery S: Cell surface association of matrix
metalloproteinase-9 (gelatinase B). Cancer Metastasis Rev.
22:153–166. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zuzga D, Gibbons AV and Li P:
Overexpression of matrix metalloproteinase 9 in tumor epithelial
cells correlates with colorectal cancer metastasis. Clin Transl
Sci. 1:136–141. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lubbe WJ, Zhou ZY, Fu W, et al: Tumor
epithelial cell matrix metalloproteinase-9 is a target for
antimetastatic therapy in colorectal cancer. Clin Cancer Res.
12:1876–1882. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Curran S and Murray GI: Matrix
metalloproteinases in tumour invasion and metastasis. J Pathol.
189:300–308. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lubbe WJ, Zuzga DS, Zhou ZY, et al:
Guanylyl cyclase C prevents colon cancer metastasis by regulating
tumor epithelial cell matrix metalloproteinase-9. Cancer Res.
69:5472–5476. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Rao JS, Bhoopathi P, Chetty C, Gujrati M
and Lakka SS: MMP-9 short interfering RNA induced senescence
resulting in inhibition of medulloblastoma growth via p16(INK4a)
and mitogen-activated protein kinase pathway. Cancer Res.
67:4956–4964. 2007. View Article : Google Scholar
|
|
48
|
Bhoopathi P, Chetty C, Kunigal S, Vanamala
SK, Rao JS and Lakka SS: Blockade of tumor growth due to MMP-9
inhibition is mediated by sequential activation of β1 integrin, ERK
and NFκB. J Biol Chem. 283:1545–1552. 2008.PubMed/NCBI
|
